BRIGHT-4: Large, 'Clean' Trial Clarifies Bivalirudin Benefits in STEMI
Experts say it’s likely too late for cath labs to stomach a bolus plus infusion, having turned back to heparin once and for all.
Source: tctmd.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Nail Out. Real-time updates on events, politics, business and more.